Henneman John B III
- SEC CIK
- 0001187572
In the past year, 2 open-market purchase filings worth $134.6K and no sales.
Current role at each company
- ANIK Anika Therapeutics, Inc.Directoras of Jun 23, 2026
- APRE Aprea Therapeutics, Inc.Directoras of Jun 17, 2026
- OFIX Orthofix Medical Inc.Directoras of Jun 12, 2026
- RCM R1 RCM Inc.Directoras of Nov 19, 2024
- SPNE SeaSpine Holdings CorpDirectoras of Jan 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $134.6K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$134.6K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Henneman John B III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OFIX Orthofix Medical Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2026 (view filing) | May 7 | 1 day | Henneman John B IIIDirector | PPurchase | +5.00K | $12.26 | +$61.3K | +5.8%90.8K after |
ANIK Anika Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 (view filing) | May 1 | 3 days | Henneman John B IIIDirector | PPurchase | +5.00K | $14.66 | +$73.3K | +10.0%54.9K after |
APRE Aprea Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 (view filing) | Mar 13 | 1 day | Henneman John B IIIDirector | PPurchase | +6.86K | $7.29 | +$50.0K | +536.4%8.14K after | |
| Mar 14, 2024 (view filing) | Mar 13 | 1 day | Henneman John B IIIDirector | PPurchase | +6.86K | – | – | –3.43K after | Derivative2 lots |
RCM R1 RCM Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 (view filing) | Aug 8 | 1 day | Henneman John B IIIDirector | SSale | −50.0K | $17.17 | −$858.5K | −40.9%72.1K after |